Reykjavík Energy (Orkuveita Reykjavíkur) has published the attached Reykjavík Energy Green Finance Impact Report 2024 – Audited, certified by the company’s independent auditors. The report is in English.
The report is issued under the provisions of Reykjavík Energy’s Green Finance Framework, which was published on October 30, 2024, and received a “Dark Green” rating from the rating agency S&P Global. It details the allocation of green loan proceeds in 2024, totalling ISK 31.3 billion.
“Since Reykjavík Energy took the lead in green financing in Iceland in 2019, the company has benefited from more favourable financing terms. Today, it is the most significant issuer of green bonds in Iceland. The reputation we have built will serve us well in the ambitious green projects ahead in energy production, utility operations,...
Biodexa Announces Successful Outcome of a Type C Meeting with FDA Regarding the Phase 3 Program for eRapa in FAP
Written by Customer Service on . Posted in Public Companies.
March 10, 2025
Biodexa Announces Successful Outcome of a Type C Meeting with FDA Regarding the Phase 3 Program for eRapa in FAP
Clears the way to finalize Phase 3 protocol and recruit sites for U.S.
Phase 3 substantially funded by $17.0 million CPRIT grant and $8.5 million Company match
Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, today announced the results of its Type C meeting with the U.S. Food and Drug Administration (“FDA”) regarding the protocol for the planned registrational Phase 3 study of eRapa in familial adenomatous polyposis (“FAP”).
The Type C meeting followed a productive End of Phase 2 meeting with FDA and the publication of Phase 2 data of eRapa in...
Serstech receives an order of 2.1 MSEK from its partner Kaiser
Written by Customer Service on . Posted in Public Companies.
Serstech has today received an order from its partner Kaiser in Singapore. The order consists of SERS consumables. The value of the order is 2.1 MSEK, and it will be delivered and invoiced in Q2 2025.
For further information, please contact:
Stefan Sandor,
CEO, Serstech AB Phone: +46 739 606 067
Email: ss@serstech.com
or
Thomas Pileby,
Chairman of the Board, Serstech AB Phone: +46 702 072 643
Email: tp@serstech.com
or visit: www.serstech.com
This is information that Serstech AB (publ.) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above at 13:30 CET on March 10, 2025.
Certified advisor to Serstech is Svensk Kapitalmarknadsgranskning AB (SKMG).
About Serstech
Serstech delivers solutions for chemical identification and...
Polyrizon Initiates Preclinical Studies for Intranasal Naloxone Targeting Opioid Overdose Based on Its Innovative T&T Platform
Written by Customer Service on . Posted in Public Companies.
Raanana, Israel, March 10, 2025 (GLOBE NEWSWIRE) — Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced today the initiation of preclinical studies for intranasal Naloxone, a life-saving opioid overdose treatment.
The study will be conducted in collaboration with Professor Fabio Sonvico, Associate Professor at the Department of Food and Drug of the University of Parma (Italy) a leading expert in the development of intranasal and pulmonary drug delivery solutions and a member of the Company’s Scientific Advisory Board.
These preclinical studies mark a step forward in evaluating Polyrizon’s Trap and Target™ (T&T) platform for the intranasal administration of Naloxone, an opioid...
SciSparc-Clearmind Collaboration Leads to Publication of Patent Application for Cocaine Addiction Psychedelic Combination Treatment in South Korea
Written by Customer Service on . Posted in Public Companies.
TEL AVIV, Israel, March 10, 2025 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (the “Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, announced today that its collaboration with Clearmind Medicine Inc. (Nasdaq: CMND) has led to the publication of a patent application by the South Korean Intellectual Property Office (“KIPO”). The patent application relates to a combination treatment using Clearmind’s 5-methoxy-2-aminoindane (“MEAI”) and SciSparc’s Palmitoylethanolamide (“PEA”) for the treatment of cocaine addiction.
The patent is based on preclinical trial results led by Professor Gal Yadid and his team at the Gonda Multidisciplinary Brain Research Center at Bar-Ilan University in Israel....
Bird Joint Venture Signs Project Alliance Agreement for East Harbour Transit Hub
Written by Customer Service on . Posted in Public Companies.
MISSISSAUGA, Ontario, March 10, 2025 (GLOBE NEWSWIRE) — Bird Construction Inc. (TSX: BDT) is pleased to announce that Rail Connect Partners, its 50/50 joint venture with AtkinsRéalis, has finalized and signed a Project Alliance Agreement with Metrolinx to deliver the East Harbour Transit Hub, that will strengthen transit options for the City of Toronto.
The execution phase of the project includes completion of the rail corridor and bridge widening over an important thoroughfare, which will continue to be undertaken in planned phases to keep GO Transit services running with minimal impact. The execution phase will also include the commencement of the station works and associated infrastructure and future road extension to facilitate a future streetcar connection.
“The Metrolinx team is proud to work with partners in government...
OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer
Written by Customer Service on . Posted in Public Companies.
Silvestro has a demonstrated record of accelerating revenue growth, expanding brand relevance, and building a market-leading team
WALTHAM, Mass., March 10, 2025 (GLOBE NEWSWIRE) — OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced it has appointed Steve Silvestro as the Company’s new Chief Executive Officer, effective March 10, 2025.
Mr. Silvestro brings to OptimizeRx more than 20 years of experience in building and managing health technology and services companies, and has served as an executive at OptimizeRx since joining the Company in 2019. His career includes strategic development, sales leadership, technology and product innovation, and M&A within a variety...
Whitestone REIT Commences Transformation of Merchandising Mix at Davenport Village in Austin, Texas
Written by Customer Service on . Posted in Public Companies.
Positioning asset to become an 18-hour activity hub that better serves the lifestyle needs of the surrounding community
Meets neighborhood demand for an upscale coffeehouse, premium fitness concepts and executive suites by bringing in Starbucks Reserve, Pvolve, RVE Fitness and CUBExec
HOUSTON, March 10, 2025 (GLOBE NEWSWIRE) — Whitestone REIT (NYSE: WSR), a neighborhood-focused owner and operator of open-air shopping centers in Texas and Arizona, today announced that it has commenced a strategic transformation of the merchandising mix at Davenport Village (“Davenport”) in Austin, Texas that is expected to re-energize the center and strengthen its competitive position within the upscale neighborhoods it serves: Davenport Ranch, Westlake, Rob Roy and Barton Creek. Whitestone is creating a vibrant, 18-hour activity hub that more appropriately...
Anfield Announces Special Shareholder Meeting and Mailing of Related Documents in Pursuit of NASDAQ Listing
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, March 10, 2025 (GLOBE NEWSWIRE) — Anfield Energy Inc. (TSX.V: AEC; OTCQB: ANLDF; FRANKFURT: 0AD) (“Anfield” or “the Company”) announces that it has filed notice of a meeting of shareholders, a management information circular, and related documents (collectively, the “Meeting Materials”) to convene a special meeting (the “Meeting”) of shareholders. The Meeting will take place on March 31, 2025 at 10:00 AM (Vancouver Time). Copies of the Meeting Materials are available for review under the profile for the Company on SEDAR+ (www.sedarplus.ca) and on Anfield’s corporate website (https://anfieldenergy.com).
The Meeting has been convened to seek shareholder approval for a consolidation (the “Consolidation”) of the Company’s common shares (“Shares”) on the basis of one new Share for up to 200 currently issued...
Traxys and HNK Alpha Execute First Lithium Carbonate Futures Block Trade on Abaxx Commodity Futures Exchange and Clearinghouse
Written by Customer Service on . Posted in Public Companies.
TORONTO, March 10, 2025 (GLOBE NEWSWIRE) — Abaxx Technologies Inc. (CBOE:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, majority shareholder of Abaxx Singapore Pte Ltd., the owner of Abaxx Commodity Exchange and Clearinghouse (individually, “Abaxx Exchange” and “Abaxx Clearing”), and producer of the SmarterMarkets™ Podcast, today announced the execution of the first lithium carbonate futures block trade, traded between Traxys and HNK Alpha on March 7, 2025.
Traxys and HNK Alpha traded 20 lots of the May 2025 Abaxx Lithium Carbonate Singapore futures contract at USD$10,300/tonne.
“We are delighted to be an active participant in the newly created Abaxx physical lithium carbonate contract,” said Martim Facada, Head of Lithium, Traxys. “As a long-term participant in the...